Potential Cancer Treatments with Ivermectin

The hypothesis is clear from this and multiple studies.

We could be curing, potentially, we don't know, but we could be curing

your wife's cancer, your husband's cancer, your mother's cancer, your father's

cancer, your son's cancer, your daughter's cancer

with ivermectin and mebendazole.

Clinical benefit ratio, as we said, 84.4%.

All right, so 48.4 of the cohort, strongest possible

outcomes. Regression, 15.6%.

No current evidence of disease, as we said, 32.8.

Disease stability, 36.1. Only

15.6%

of the whole cohort

were progressing,

which is remarkably good. Remarkably good.